An audience member seated near a Microsoft logo listens as Microsoft Chairman and Chief Executive Officer Satya Nadella speaks during the Microsoft Build conference opening keynote in Seattle, ...

Claude Opus 4.8 allows for remote response and execution. Anthropic.com Anthropic released Claude Opus 4.8 on Thursday, upgrading its flagship artificial intelligence model worldwide with a pitch ...

Voice agents have been expensive to run and painful to orchestrate, not because the models can't handle conversation, but because context ceilings forced enterprises to build session resets, state ...

GPT-Realtime-2 brings GPT-5-class reasoning to live voice. A separate translation model covers 70+ input languages. A streaming Whisper variant handles transcription. The pricing is aggressive enough ...

PCWorld reports that OpenAI has launched GPT-5.5, its most advanced AI model, exclusively for paying ChatGPT subscribers on Plus, Pro, Business, and Enterprise plans. The new model delivers faster, ...

Late in Sunday's win over the Baltimore Ravens, it looked like Pittsburgh Steelers kicker Chris Boswell was going to be the scapegoat if Pittsburgh lost. His missed extra point put Baltimore in a ...

OpenAI Group PBC today launched a new large language model that is significantly better than its predecessors at solving math problems and writing code. GPT-5.5 is rolling out a week after rival ...

GPT-5.5 lands seven weeks after the release of GPT-5.4, which arrived on March 5. OpenAI says the newest model “understands what you’re trying to do faster” and that it can “carry more of the work ...

The new model ‘excels’ at tasks like writing and debugging code and doing work across different tools. The new model ‘excels’ at tasks like writing and debugging code and doing work across different ...

The system represents an improvement in autonomous or agentic capability. GPT-5.5 “represents a step toward AI systems that can complete complex, multistep tasks on a computer without human guidance,” ...

OpenAI is already working with biopharma and research organizations—including Amgen, Moderna, the Allen Institute and Thermo Fisher Scientific—to apply the technology across the discovery process.